Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $0.32 in the last session, down -4.41% from day before closing price of $0.34. In other words, the price has decreased by -$4.41 from its previous closing price. On the day, 4.85 million shares were traded. RVPH stock price reached its highest trading level at $0.3588 during the session, while it also had its lowest trading level at $0.321.
Ratios:
We take a closer look at RVPH’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $2.
On September 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $12.
On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.The Benchmark Company initiated its Speculative Buy rating on June 08, 2023, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 37976228 and an Enterprise Value of 24210792.
Stock Price History:
The Beta on a monthly basis for RVPH is 0.07, which has changed by -0.7848101 over the last 52 weeks, in comparison to a change of 0.19226205 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $2.15, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -36.05%, while the 200-Day Moving Average is calculated to be -44.19%.
Shares Statistics:
According to the various share statistics, RVPH traded on average about 7.46M shares per day over the past 3-months and 6476900 shares per day over the past 10 days. A total of 115.06M shares are outstanding, with a floating share count of 110.11M. Insiders hold about 4.30% of the company’s shares, while institutions hold 8.41% stake in the company. Shares short for RVPH as of 1767139200 were 21464180 with a Short Ratio of 2.88, compared to 1764288000 on 23151800. Therefore, it implies a Short% of Shares Outstanding of 21464180 and a Short% of Float of 19.18.
Earnings Estimates
The market rating of Reviva Pharmaceuticals Holdings Inc (RVPH) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.03 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.28 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.27, with 7.0 analysts recommending between -$0.11 and -$0.85.
